First patients dosed with novel NAD+ precursor d
Author: Michael
New £4.
Celebrity-backed proactive health platform wants
CRISPR-modified human iPSC-microglia respond to
Coya’s biologic therapeutic aims to suppress c
Metabolic feature of mutant stem cells offers a
New initiative to drive advancements in longevit
New data from a 12-week trial indicate that trea
Seveno Capital makes first investment and launch
Elevate Chief Medical Officer Nitin Shori on why